NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Istituto Oncologico Veneto IRCCS
First Affiliated Hospital of Zhejiang University
Fundación GECP
Guangdong Association of Clinical Trials
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Sungkyunkwan University